Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Accured Expenses (2017 - 2021)

Cogent Biosciences has reported Change in Accured Expenses over the past 5 years, most recently at $1.2 million for Q4 2021.

  • Quarterly results put Change in Accured Expenses at $1.2 million for Q4 2021, up 253.84% from a year ago — trailing twelve months through Dec 2021 was $3.4 million (up 245.88% YoY), and the annual figure for FY2025 was $10.7 million, down 33.03%.
  • Change in Accured Expenses for Q4 2021 was $1.2 million at Cogent Biosciences, up from $602000.0 in the prior quarter.
  • Over the last five years, Change in Accured Expenses for COGT hit a ceiling of $3.7 million in Q2 2021 and a floor of -$2.0 million in Q1 2021.
  • Median Change in Accured Expenses over the past 5 years was $396000.0 (2017), compared with a mean of $344500.0.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 259.42% in 2020 and later surged 844.96% in 2021.
  • Cogent Biosciences' Change in Accured Expenses stood at $454000.0 in 2017, then plummeted by 127.31% to -$124000.0 in 2018, then skyrocketed by 578.23% to $593000.0 in 2019, then tumbled by 227.49% to -$756000.0 in 2020, then surged by 253.84% to $1.2 million in 2021.
  • The last three reported values for Change in Accured Expenses were $1.2 million (Q4 2021), $602000.0 (Q3 2021), and $3.7 million (Q2 2021) per Business Quant data.